Disposition of 20000 shares by Ming Yan of Cytek Biosciences at 6.77 subject to Rule 16b-3
| 1736 Stock | TWD 173.50 7.00 3.88% |
Slightly above 62% of Johnson Health's investor base is looking to short. The analysis of current outlook of investing in Johnson Health Tech suggests that many traders are alarmed regarding Johnson Health's prospects. Johnson Health's investing sentiment can be driven by a variety of factors including economic data, Johnson Health's earnings reports, geopolitical events, and overall market trends.
Johnson Health stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Johnson daily returns and investor perception about the current price of Johnson Health Tech as well as its diversification or hedging effects on your existing portfolios.
Johnson |
Filed transaction by Cytek Biosciences Director, Officer: Chief Technology Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Johnson Health Fundamental Analysis
We analyze Johnson Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Johnson Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Johnson Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Johnson Health is currently under evaluation in target price category among its peers.
Johnson Health Tech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Johnson Health stock to make a market-neutral strategy. Peer analysis of Johnson Health could also be used in its relative valuation, which is a method of valuing Johnson Health by comparing valuation metrics with similar companies.
Peers
Johnson Health Related Equities
| 1722 | Taiwan Fertilizer | 0.20 |
| ||
| 1707 | Grape King | 1.01 |
| ||
| 1717 | Eternal Materials | 1.62 |
| ||
| 1515 | Rexon Industrial | 2.72 |
| ||
| 9921 | Giant Manufacturing | 4.50 |
|
Additional Tools for Johnson Stock Analysis
When running Johnson Health's price analysis, check to measure Johnson Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Health is operating at the current time. Most of Johnson Health's value examination focuses on studying past and present price action to predict the probability of Johnson Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Health's price. Additionally, you may evaluate how the addition of Johnson Health to your portfolios can decrease your overall portfolio volatility.